Filing Details
- Accession Number:
- 0001209191-13-045956
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-27 16:56:56
- Reporting Period:
- 2013-09-25
- Filing Date:
- 2013-09-27
- Accepted Time:
- 2013-09-27 16:56:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385228 | Bind Therapeutics Inc | BIND | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1255927 | Jr M Edwin Kania | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | No | No | Yes | No | |
| 1299790 | P L 2004 Fund Ventures Flagship | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | No | No | Yes | No | |
| 1400249 | Flagship Ventures General Partner Llc | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-25 | 1,542,616 | $0.00 | 1,542,616 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2013-09-25 | 20,000 | $15.00 | 1,562,616 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2013-09-25 | 984,640 | $0.00 | 375,816 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2013-09-25 | 1,900,000 | $0.00 | 725,190 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2013-09-25 | 416,667 | $0.00 | 159,033 | $0.00 |
| Common Stock | Series C-1 Preferred Stock | Disposition | 2013-09-25 | 333,288 | $0.00 | 127,209 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2013-09-25 | 407,060 | $0.00 | 155,366 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date. Immediately prior to closing of the issuer's initial public offering, the preferred stock held by the reporting person automatically converted into common stock on a 2.62 to 1 basis.
- Held by Flagship Ventures Fund 2004, L.P. ("Flagship 2004"). Flagship Ventures General Partner LLC ("Flagship LLC") is the general partner of Flagship 2004. Noubar B. Afeyan Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship LLC. Flagship LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship 2004. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. Dr. Afeyan, a director of the issuer, is filing a separate Form 4.
Billionaire Hedge Funds
